1 / 10

SAFE-BioPharma Association

SAFE-BioPharma Association. SAFE is a member-governed, not-for-profit enterprise that: Manages and promotes the SAFE standard Provides a legal and contractual framework Provides technical infrastructure to bridge different credentialing systems

sderosa
Télécharger la présentation

SAFE-BioPharma Association

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. SAFE-BioPharma Association • SAFE is a member-governed, not-for-profit enterprise that: • Manages and promotes the SAFE standard • Provides a legal and contractual framework • Provides technical infrastructure to bridge different credentialing systems • Provides SAFE identity credentials, both directly and through vendors • Supports vendors who supply SAFE-enabled products. • SAFE project initiated in November 2003

  2. Pharma X Pharma C Pharma B Site ID User ID/ Password Pharma A Pharma D SAFE Key to Scalability • Current environment • Many Credentials • Access control Only • Physical paper signing required • High user complexity • High cost • SAFE environment • One Credential • Access control and eSignature • Eliminate paper signatures • Lower aggregate costs

  3. SAFE-BioPharma Association • SAFE-BioPharma Association incorporated May 2005 • AstraZeneca • Bristol-Myers Squibb • GlaxoSmithKline • Genzyme • Johnson & Johnson • Merck • Nektar • Organon • Pfizer • Procter & Gamble • Roche • Sanofi-Aventis

  4. SAFE Infrastructure

  5. Pfizer: eLab Notebooks Regulatory submissions AstraZeneca: 150+ regulatory submissions via FDA’s ESG: 2252, 1571, 356h and eCTD GSK: eCTD submissions J&J: All J&J certificates are SAFE P&G: Enterprise digital signature 4,500 eLab Notebooks ePurchasing eHR – forms ePatent Filings BMS: External partner authentication Member Implementations

  6. SAFE And The FDA • SAFE Member reps with QA/Compliance/Reg backgrounds • FDA key offices engaged since inception • Jointly-developed SAFE/FDA Auditor Familiarization Program • FDA statement on SAFE • Complies with appropriate guidance, especially as related to 21CFR11 • When used as the basis for implementation of a digital signature capability, the SAFE standard facilitates user compliance with 21CFR11 • SAFE-FDA Auditor/Compliance Workshop • Training audit of SAFE-signed submission The FDA’s goal is to eliminate paper from application receipt and review processes. A paperless application process must include legally binding electronic signatures.

  7. SAFE EMEA Pilot • Participants • SAFE Evaluation Team: EMEA, GSK, Organon, Pfizer • SAFE EU Advisory Council • EU and Member State regulations • EU implementations • Next Steps • eCTD submission by SAFE member • Auditor workshop – EMEA and Member State Regulators The SAFE Evaluation Team (EMEA, EFPIA, Companies) determined that SAFE meets EU Electronic Signature and Clinical Trial Directives requirements.

  8. SAFE Vendor Partners SAFE Partners • ARX • DataLabs • IntraLinks • Solabs • Open Text SAFE Premier Partners • Adobe • Aladdin • Arcot • Bearing Point • CoreStreet • Cybertrust • IBM • IDBS • Microsoft • Northrop Grumman SAFE Issuers • Citibank • Cybertrust • IdenTrust • J&J • BMS • P&G

  9. Technical Current/Future Developments • FBCA cross certification • In progress, mid-2007 • Token-less Credentials • Simplify deployment to Research Partners

  10. Johnson & Johnson PKI • Existing PKI Cross certified with SAFE September 2005 • Issued ~75,000 certificates to date (employees, partners) • Regulatory Filings • Remote Access (VPN) • Policies require two-factor authentication • Signed/Encrypted email • Certificate-based logon – to the LAN and applications • Hard disk (“media”) and file/folder encryption • Digital Signatures • QA documentation • System Build documentation • Site Monitor Trip Reports • E-Trial Master File application

More Related